Accelerated digital transformation: a customer-first approach when engaging with HCPs

A recent article on by Paul Shawah, Executive Vice President of Commercial Strategy at Veeva Systems, highlighted the opportunity COVID has presented for pharma to accelerate digital transformation. It has forced the adoption of digital engagement channels and as a result, has become a real ‘game-changer’ for the pharma industry.

Pharma companies have responded by adopting ‘digital-first’ strategies which focus on providing the customer with more relevant and accessible content – a move welcomed by HCPs, who support remote engagement, as well as reps who are reaching significantly more HCPs than before the pandemic.

The article explains the impact of the customer-first approach. It highlights how customising messaging and delivery channel to each HCP works to ensure greater engagement and advocacy. This targeted approach also delivers valuable insights which helps inform future communications, allowing pharma companies to better meet customer needs, by futher deepening relationships through personalisation; applying targeted, digital marketing and focusing on key preferences, based on valuable data insights.

Adding delivery of published scientific content directly to the HCP, supports this approach and drives a better outcome. Tangent90’s Trustrack solution enables commercial and medical teams to send copyright scientific content through Veeva Approved Email and other channels, whilst protecting copyright, recording transfer of value in line with local regulations such as the Sunshine Act and the EFPIA disclosure code, and delivering an optimal experience for the HCP.

To find out more about how Tangent90 can support your digital strategy requirements, please contact us at

To read the full article from Paul Shawah on, click here.

Related news

Omnichannel metrics

Measuring omnichannel success

What does success look like? Is it simply proving return on investment – the thing all marketers talk about, and one of the hardest things to provide tangible evidence for?! Or are there other measures of success that can deliver the reassurance that the approach taken is the right one?

New technologies for HCP engagement

Is pharma investing in the right digital solutions?

Digital transformation has gathered pace in pharma and we have all been witnessing the acceleration. New technologies have been adopted to ensure HCP engagement is maintained but keeping up the understanding of innovative and emerging solutions and investing in the right technologies may prove challenging.

Scroll to Top

Book A Demo

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.